黄芪注射液辅助治疗小儿肺炎支原体肺炎疗效观察

Curative effect observation of radix astragali injection in adjunctive treatment pediatric patients with mycoplasma pneumoniae pneumonia

目的:观察黄芪注射液辅助治疗小儿肺炎支原体肺炎的疗效。方法:将120例小儿肺炎支原体肺炎患儿随机分为两组,对照组60例采用常规阿奇霉素治疗,治疗组在常规阿奇霉素治疗基础上加用黄芪注射液静脉滴注,疗程为2周。观察两组患儿在治疗过程中的症状、体征、胸片及不良反应情况,比较两组的疗效。结果:治疗组和对照组的总有效率分别为96.67%和83.33%,治疗组疗效优于对照组(P<0.05);治疗组退热时间、咳嗽、肺部体征持续时间及X线阴影消失时间、住院时间均较对照组明显缩短(P<0.05)。结论:黄芪注射液辅助治疗小儿肺炎支原体肺炎,临床症状、体征消失快,治愈率高,疗效显著。

Objective：To investigate the curative effect of radix astragali injection in adjunctive treatment of children with mycoplasma pneumoniae pneumonia（MPP）.Methods：120 cases of children with MPP were randomly divided into two groups with 60 cases each,the treatment group received the combined therapy of azithromycin with radix astragali injection,while the control group received the therapy of azithromycin only.The clinical symptoms,signs,chest radiograph and adverse reactions in the two groups were observed,and then comparison was made between the two groups in clinical effects in the end of the course of 2 weeks＇ treatment.Results：The treatment group total effective rate for 96.67%,was higher than the control group 83.33%（P0.05）.There was significant difference between the two groups（P0.05） in the time of the disappearance of fever,cough and pulmonary signs,X-ray recovery,and length of stay.Conclusion：The combined therapy of azithromycin with radix astragali injection has obvious superiority with shorter clinical symptom and sign average recovery time,and has a high curative rate than single azithromycin in treatment of children with MPP.